Xiaohua Xue, MD, MSc, joined RayThera in September 2023 as an Executive Director and was promoted to VP of Biology in July 2024. Xiaohua has over 20 years of experience in the pharmaceutical industry, primarily focusing on the discovery and development of small molecules targeting inflammatory and autoimmune diseases. Before joining RayThera, Xiaohua served as a Scientific Director in Immunology Discovery at Janssen Pharmaceuticals, where she contributed both scientifically and strategically to the discovery portfolio and led cross-functional teams, delivering multiple development candidates, including clinical-stage assets. She is a seasoned project leader with extensive knowledge from target validation to FIH (First-In-Human) studies. Xiaohua has co-authored over 40 journal papers and poster presentations and co-invented more than 15 patents. Xiaohua earned an MD in Clinical Medicine from Inner Mongolia Medical University, an MSc in Microbiology from Tianjin Medical University, and an MSc in Molecular Physiology from Simon Fraser University.
